帕金森病患者与对照组的血小板单胺氧化酶活性及单胺氧化酶B蛋白浓度 - Suppr | 超能文献

Platelet MAO activities and MAO-B protein concentrations in Parkinson's disease and controls.

作者信息

Finch C C, Ho S L, Williams A C, Billett E E

机构信息

Department of Life Sciences, Nottingham Trent University, UK.

出版信息

Prog Brain Res. 1995;106:85-90. doi: 10.1016/s0079-6123(08)61205-4.

DOI:10.1016/s0079-6123(08)61205-4

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Platelet MAO activities and MAO-B protein concentrations in Parkinson's disease and controls.帕金森病患者与对照组的血小板单胺氧化酶活性及单胺氧化酶B蛋白浓度

Prog Brain Res. 1995;106:85-90. doi: 10.1016/s0079-6123(08)61205-4.

2

Altered platelet monoamine oxidase-B activity in idiopathic Parkinson's disease.特发性帕金森病患者血小板单胺氧化酶-B活性的改变

Neurochem Res. 2009 Aug;34(8):1427-32. doi: 10.1007/s11064-009-9929-4. Epub 2009 Mar 4.

3

Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation.帕金森病中血小板单胺氧化酶B活性：重新评估

J Neural Transm Park Dis Dement Sect. 1993;5(1):1-4. doi: 10.1007/BF02260909.

4

Platelet monoamine oxidase B activity in parkinsonian patients.帕金森病患者的血小板单胺氧化酶B活性

J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):854-5. doi: 10.1136/jnnp.53.10.854.

5

Substrate specificity of human platelet monoamine oxidase B activity Parkinson's and Alzheimer's disease.人类血小板单胺氧化酶B活性的底物特异性与帕金森病和阿尔茨海默病

Biochem Soc Trans. 1996 Feb;24(1):63S. doi: 10.1042/bst024063s.

6

Platelet monoamine oxidase B activity in "de novo" and l-dopa treated parkinsonian patients and controls.“初发”及左旋多巴治疗的帕金森病患者与对照组的血小板单胺氧化酶B活性

Can J Neurol Sci. 1998 Aug;25(3):249-51. doi: 10.1017/s0317167100034090.

7

Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease.帕金森病患者外周血细胞中B型单胺氧化酶和超氧化物歧化酶的活性

J Neural Transm Park Dis Dement Sect. 1992;4:283-90. doi: 10.1007/BF02260077.

8

Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease.帕金森病中的血小板单胺氧化酶B和血浆β-苯乙胺

J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):229-31. doi: 10.1136/jnnp.70.2.229.

9

Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients.帕金森病和多系统萎缩患者的全血单胺氧化酶活性

J Neurol Sci. 1993 Jul;117(1-2):41-5. doi: 10.1016/0022-510x(93)90152-o.

10

Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase.神经和精神疾病的分子生物学。I.帕金森病、年龄、性别及左旋多巴对血小板单胺氧化酶的影响。

J Neural Transm. 1976;39(1-2):63-77. doi: 10.1007/BF01248766.

引用本文的文献

1

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats.恩格列净通过抗氧化、抗炎以及调节大鼠鱼藤酮诱导的帕金森病中α-突触核蛋白和帕金蛋白水平来减轻神经退行性变。

Saudi Pharm J. 2022 Jun;30(6):863-873. doi: 10.1016/j.jsps.2022.03.005. Epub 2022 Mar 16.